AGAPE ATP
ATPC
3 hedge funds and large institutions have $310K invested in AGAPE ATP in 2026 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
349% more capital invested
Capital invested by funds: $69K → $310K (+$241K)
50% more funds holding
Funds holding: 2 → 3 (+1)
7.85% more ownership
Funds ownership: 2.62% → 10.47% (+7.8%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$169K |
| 2 |
Jane Street
New York
|
+$63.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$7.4K |
ATPC Hedge Fund Activity: Q2 2026 in Review
3 of the 8,329 institutional investors tracked by Wall St. Rank reported a position in AGAPE ATP (ATPC) for Q2 2026, worth a combined $310K — up 349% from $69K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new ATPC positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was HRT Financial, opening a new position worth an estimated $169K. The largest seller was UBS Group, cutting an estimated $7.4K.
- 3 institutional investors held AGAPE ATP (ATPC) as of Q2 2026, up from 2 in Q1 2026.
- Funds reported $310K of AGAPE ATP stock for Q2 2026, up 349% quarter-over-quarter.
- 1 fund opened new AGAPE ATP positions in Q2 2026 and 0 closed out, a net change of +1 holder.
- The largest AGAPE ATP buyer in Q2 2026 was HRT Financial, an estimated $169K added.
- The largest AGAPE ATP seller in Q2 2026 was UBS Group, an estimated $7.4K sold.
Based on aggregated 13F filings for Q2 2026.